文献速递创面修复显微修复重建

下肢慢性静脉性溃疡游离皮瓣重建结局的系统评价

Outcomes of Free Flap Reconstruction for Chronic Venous Ulceration in the Lower Limb: A Systematic Review.
PubMed 文献 · Ann Plast Surg · 2022-06-11

该系统评价纳入5项非比较性队列研究、56例患者共62处顽固性静脉性溃疡、64块游离皮瓣,平均年龄50岁(范围17-76岁),清创后平均缺损面积153.3 cm²(范围24-600 cm²)。皮瓣总存活率为95%,皮瓣范围内未见复发,但皮瓣边界外出现20处(35.7%)新溃疡。作者认为目前缺乏证据支持游离皮瓣重建优于传统治疗,其技术可行但无证据表明能预防重建区域外溃疡,需进一步研究评估其有效性。

要点

  • 纳入5项非比较性队列研究,共56例患者、62处溃疡、64块游离皮瓣。
  • 皮瓣总存活率95%,皮瓣范围内无复发,皮瓣外新溃疡20处(35.7%)。
  • 作者认为缺乏证据支持游离皮瓣重建优于传统治疗,需进一步研究。

核心结论

  • 目前缺乏证据支持对顽固性静脉性溃疡采用游离皮瓣重建优于传统治疗。
  • 证据提示该技术可行,但无证据表明其能预防重建区域以外的溃疡。
  • 需进一步研究评估游离皮瓣重建对下肢静脉性溃疡的有效性。

研究设计与样本

  • 系统评价,方案预先制定并注册于PROSPERO数据库。
  • 检索MEDLINE、EMBASE、Cochrane对照试验中心注册库(CENTRAL)、临床试验注册库及OpenGrey,自建库至2020年4月,遵循PRISMA指南。
  • 纳入5项非比较性队列研究,共56例患者、62处顽固性静脉性溃疡、64块游离皮瓣,平均年龄50岁(范围17-76岁),行叙述性分析。

主要发现

  • 清创后平均缺损面积为153.3 cm²(范围24-600 cm²)。
  • 缺损以肌瓣(n=39,60.9%)、筋膜皮瓣(n=23,35.9%)和内脏瓣(n=2,3.1%)重建,最常用为背阔肌瓣(n=16,25%)和腹直肌瓣(n=16,25%)。
  • 平均随访时间为24至125个月。
  • 皮瓣总存活率为95%。
  • 皮瓣范围内未见溃疡复发,但皮瓣边界外出现20处(35.7%)新溃疡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究均为非比较性队列研究,缺乏与传统治疗比较的证据。
  • 作者指出需进一步研究评估游离皮瓣重建对下肢静脉性溃疡的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The mainstay of treatment for venous ulceration is conservative wound management and lifelong compression therapy. For patients with recalcitrant ulcers, free flap reconstruction has been proposed as a treatment option to reconstruct the diseased soft tissues as well as the underlying insufficient venous system. This review systematically evaluates the outcomes of free flap reconstruction for chronic venous ulcers in the lower limb. METHOD: A protocol was developed a priori and registered on the PROSPERO database. A systematic search of literature was performed in MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), clinical trials registries, and OpenGrey from inception to April 2020 according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Studies of patients undergoing free tissue transfer reconstruction for chronic venous ulcers in the lower limb were included. RESULTS: A total of 5 noncomparative cohort studies featuring 56 patients with 62 recalcitrant venous ulcers treated with 64 free flaps who had a mean age of 50 years (range, 17-76 years) were included, and a narrative analysis undertaken. Mean defect size following ulcer debridement was 153.3 cm 2 (range, 24-600 cm 2 ). Defects were reconstructed with muscle (n = 39 [60.9%]), fasciocutaneous (n = 23 [35.9%]), and visceral (n = 2 [3.1%]) free flaps, with latissimus dorsi (n = 16, 25%) and rectus abdominis flaps (n = 16, 25%) being the most frequently used. Mean follow-up ranged from 24 to 125 months. Pooled flap survival rate was 95%. No recurrence within the territory of the flap was reported, but there were 20 instances (35.7%) of new ulcers outside of the flap boundaries. CONCLUSION: There is currently an absence of evidence to support the use of free flap reconstruction for recalcitrant venous ulcers compared with conventional management. Although evidence suggests that it is technically feasible, there is no evidence to suggest it prevents ulceration outside the reconstructed region. Further studies are necessary to evaluate its effectiveness for venous ulcers in the lower limb.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Song MSH, Baldwin AJ, Wormald JCR, et al. Outcomes of Free Flap Reconstruction for Chronic Venous Ulceration in the Lower Limb: A Systematic Review. Ann Plast Surg. 2022. PMID: 35703233. doi:10.1097/SAP.0000000000003249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。